Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug…
Month: February 2021
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging…
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage…
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Adverum Appoints Christopher J. DeRespino as Chief Business Officer
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Pipeline and capital for growth
Key 2020 events: Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan Gilead decided…
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using…
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
CBD Companies Will Lose Market Share to Delta 8 THC Hemp Products in 2021
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
WATERTOWN, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage…
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic…
Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical…
Allogene Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
Conference call and webcast to be held at 10:00 a.m. ET BOSTON, Feb. 18, 2021…
Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
TRACON to Report Fourth Quarter and Full Year 2020 Financial Results and Company Highlights on February 25, 2021
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors
MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…